MedPath

Observational study of neoadjuvant GS chemotherapy for patients with pancreatic cancer

Phase 1
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000025675
Lead Sponsor
Dokkyo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1)patients with lung fibrosis and/or interstitial pneumoniae 2)unresectable SMA invasion 3)active double cancer 4)active infectious disease 5)creatinine clearance < 30mL/min

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath